H. Abraha

973 total citations
18 papers, 767 citations indexed

About

H. Abraha is a scholar working on Molecular Biology, Epidemiology and Neurology. According to data from OpenAlex, H. Abraha has authored 18 papers receiving a total of 767 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Epidemiology and 5 papers in Neurology. Recurrent topics in H. Abraha's work include S100 Proteins and Annexins (9 papers), Traumatic Brain Injury and Neurovascular Disturbances (5 papers) and Acute Ischemic Stroke Management (4 papers). H. Abraha is often cited by papers focused on S100 Proteins and Annexins (9 papers), Traumatic Brain Injury and Neurovascular Disturbances (5 papers) and Acute Ischemic Stroke Management (4 papers). H. Abraha collaborates with scholars based in United Kingdom. H. Abraha's co-authors include Roy Sherwood, John Garthwaite, Richard Butterworth, Wassif S. Wassif, Philip M. Bath, Elisabeth M. Higgins, L. Claire Fuller, Caje Moniz, ANTHONY VIVIER and P. L. Noble and has published in prestigious journals such as Journal of the American Geriatrics Society, Transplantation and Heart.

In The Last Decade

H. Abraha

18 papers receiving 731 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H. Abraha United Kingdom	16	349	194	176	133	112	18	767
R J Butterworth United Kingdom	8	515 1.5×	127 0.7×	252 1.4×	51 0.4×	518 4.6×	19	1.5k
P Madoz Spain	18	146 0.4×	120 0.6×	382 2.2×	66 0.5×	53 0.5×	48	1.2k
Hiroyuki Takatsuka Japan	18	154 0.4×	215 1.1×	197 1.1×	18 0.1×	148 1.3×	65	1.3k
E Ogris Austria	18	131 0.4×	42 0.2×	56 0.3×	57 0.4×	148 1.3×	66	1.2k
Giuseppe Madeddu Italy	17	36 0.1×	143 0.7×	127 0.7×	206 1.5×	140 1.3×	59	893
Miguel Hernandez‐Pampaloni United States	16	76 0.2×	187 1.0×	127 0.7×	244 1.8×	82 0.7×	26	1.1k
José C. Milisenda Spain	17	387 1.1×	198 1.0×	888 5.0×	18 0.1×	79 0.7×	69	1.4k
Sara Reis Teixeira Brazil	13	137 0.4×	41 0.2×	64 0.4×	53 0.4×	24 0.2×	49	579
B. A. C. Dijkmans Netherlands	18	106 0.3×	85 0.4×	80 0.5×	27 0.2×	51 0.5×	37	1.2k
Robert W. Siggins United States	20	241 0.7×	40 0.2×	169 1.0×	34 0.3×	52 0.5×	35	735

Countries citing papers authored by H. Abraha

Since Specialization

Citations

This map shows the geographic impact of H. Abraha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Abraha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Abraha more than expected).

Fields of papers citing papers by H. Abraha

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Abraha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Abraha. The network helps show where H. Abraha may publish in the future.

Co-authorship network of co-authors of H. Abraha

This figure shows the co-authorship network connecting the top 25 collaborators of H. Abraha. A scholar is included among the top collaborators of H. Abraha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Abraha. H. Abraha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

1.

Abraha, H., et al.. (2010). Mitotane treatment has profound effects on cortisol catabolism. 21. 1 indexed citations

2.

Simpson, Colin R, R. Sherwood, H. Abraha, et al.. (2007). Prediction of cognitive dysfunction after resuscitation from out-of-hospital cardiac arrest using serum neuron-specific enolase and protein S-100. Heart. 93(10). 1268–1273. 68 indexed citations

3.

Pereira, Stephen P., J. O’Donohue, C. Moniz, et al.. (2004). Transdermal hormone replacement therapy improves vertebral bone density in primary biliary cirrhosis: results of a 1‐year controlled trial. Alimentary Pharmacology & Therapeutics. 19(5). 563–570. 35 indexed citations

4.

Acland, K., A. V. Evans, H. Abraha, et al.. (2002). Serum S100 concentrations are not useful in predicting micrometastatic disease in cutaneous malignant melanoma. British Journal of Dermatology. 146(5). 832–835. 25 indexed citations

5.

Allain, Theresa J., H. Abraha, Emma Ouldred, et al.. (2002). Diurnal, Week‐to‐Week, and Long‐Term Variation in Urine Deoxypyridinoline Cross‐Link Excretion in Healthy Older Women. Journal of the American Geriatrics Society. 50(11). 1866–1870. 2 indexed citations

6.

D’Antiga, Lorenzo, Caje Moniz, M. Buxton‐Thomas, et al.. (2002). Bone mineral density and height gain in children with chronic cholestatic liver disease undergoing transplantation. Transplantation. 73(11). 1788–1793. 32 indexed citations

7.

Retsas, Spyros, et al.. (2001). Serum S100β Protein as a Marker of Disease Activity in Patients with Malignant Melanoma. Medical Oncology. 18(2). 109–120. 38 indexed citations

8.

McIntyre, Emily, H. Abraha, Petros Perros, & Roy Sherwood. (2000). Serum S‐100β protein is a potential biochemical marker for cerebral oedema complicating severe diabetic ketoacidosis. Diabetic Medicine. 17(11). 807–809. 17 indexed citations

9.

Strachan, Mark W. J., H. Abraha, Roy Sherwood, et al.. (1999). Evaluation of serum markers of neuronal damage following severe hypoglycaemia in adults with insulin-treated diabetes mellitus. Diabetes/Metabolism Research and Reviews. 15(1). 5–12. 15 indexed citations

10.

Abraha, H., P. L. Noble, K. H. Nicolaides, & Roy Sherwood. (1999). Maternal serum S100 protein in normal and Down syndrome pregnancies. Prenatal Diagnosis. 19(4). 334–336. 19 indexed citations

11.

Stefanis, Nicholas C., et al.. (1998). Dissociation of Bone Turnover in Anorexia Nervosa. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 35(6). 709–716. 36 indexed citations

12.

Noble, P. L., R. J. M. Snijders, H. Abraha, Roy Sherwood, & K. H. Nicolaides. (1997). Maternal serum free β‐hCG at 10 to 14 weeks of gestation in trisomic twin pregnancies. BJOG An International Journal of Obstetrics & Gynaecology. 104(6). 741–743. 27 indexed citations

13.

Gough, Andrew, H. Abraha, TS Purewal, et al.. (1997). Measurement of Markers of Osteoclast and Osteoblast Activity in Patients with Acute and Chronic Diabetic Charcot Neuroarthropathy. Diabetic Medicine. 14(7). 527–531. 111 indexed citations

14.

Abraha, H., L. Claire Fuller, ANTHONY VIVIER, Elisabeth M. Higgins, & Roy Sherwood. (1997). Serum S-100 protein: a potentially useful prognostic marker in cutaneous melanoma. British Journal of Dermatology. 137(3). 381–385. 39 indexed citations

15.

Abraha, H., Richard Butterworth, Philip M. Bath, et al.. (1997). Serum S-100 Protein, Relationship to Clinical Outcome in Acute Stroke. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 34(5). 546–550. 115 indexed citations

16.

Abraha, H., Richard Butterworth, Philip M. Bath, et al.. (1997). Serum S-100 Protein, Relationship to Clinical Outcome in Acute Stroke. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 34(4). 366–370. 75 indexed citations

17.

Abraha, H., L. Claire Fuller, ANTHONY VIVIER, Elisabeth M. Higgins, & Roy Sherwood. (1997). Serum S-100 protein: a potentially useful prognostic marker in cutaneous melanoma. British Journal of Dermatology. 137(3). 381–385. 67 indexed citations

18.

Noble, P. L., H. Abraha, R. J. M. Snijders, Roy Sherwood, & K. H. Nicolaides. (1995). Screening for fetal trisomy 21 in the first trimester of pregnancy: maternal serum free β‐hCG and fetal nuchal translucency thickness. Ultrasound in Obstetrics and Gynecology. 6(6). 390–395. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact